Baxter International, Inc.’s European subsidiary has received a contract from the National Health Service (NHS) in the UK to produce a stockpile of two million doses of candidate H5N1 influenza vaccine based on an avian strain. Under the agreement, Baxter will complete delivery of the stockpile to the NHS in 2006. “We are proud to provide the necessary technology, manufacturing capability and other resources to assist the National Health Service in its efforts to protect individ...